Tetraphase Pharmaceu
(TTPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Sales | 1,898 | 2,166 | 3,722 | 2,700 | 3,240 |
| Gross Profit | 1,898 | 2,166 | 3,722 | 2,700 | 3,240 |
| Operating Expenses | 12,821 | 11,852 | 8,680 | 5,323 | 5,942 |
| Operating Income | -10,923 | -9,686 | -4,958 | -2,623 | -2,702 |
| Interest Expense | 385 | 433 | 470 | 431 | 369 |
| Other Income | 5 | 3 | 2 | 263 | 19 |
| Pre-tax Income | -11,303 | -10,116 | -5,426 | -2,791 | -3,052 |
| Net Income Continuous | -11,303 | -10,116 | -5,426 | -2,791 | -3,052 |
| Net Income | $-11,303 | $-10,116 | $-5,426 | $-2,791 | $-3,052 |
| EPS Basic Total Ops | 9.60 | -9.80 | -5.20 | -30.20 | -479.40 |
| EPS Basic Continuous Ops | 9.70 | -9.79 | -5.27 | -30.21 | -480.57 |
| EPS Diluted Total Ops | 9.60 | -9.80 | -5.20 | -30.20 | -479.40 |
| EPS Diluted Continuous Ops | 9.70 | -9.79 | -5.27 | -30.21 | -480.57 |
| EBITDA(a) | $-10,820 | $-9,567 | $-4,829 | $-2,503 | $-2,561 |